Author:
Greenberg Dan,Hammerman Ariel,Vinker Shlomo,Shani Adi,Yermiahu Yuval,Neumann Peter J
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference30 articles.
1. Bach PB: Limits on Medicare’s ability to control rising spending on cancer drugs. N Engl J Med. 2009, 360: 626-633. 10.1056/NEJMhpr0807774.
2. Bach PB, Saltz LB, Witter RE: Cancer Care, Cost Matters. 2012, New York Times, Available at:
http://www.nytimes.com/2012/10/15/opinion/a-hospital-says-no-to-an-11000-a-month-cancer-drug.html?_r=0
3. Meropol NJ, Schulman KA: Cost of cancer care: issues and implications. J Clin Oncol. 2007, 25: 180-186. 10.1200/JCO.2006.09.6081.
4. Danzon PM, Taylor E: Drug pricing and value in oncology. Oncologist. 2010, 15 (suppl 1): 24-31.
5. Neumann PJ, Bliss SK, Chambers JD: Therapies for advanced cancers pose a special challenge for health technology assessment organizations in many countries. Health Aff. 2012, 31: 700-708. 10.1377/hlthaff.2011.1309.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献